Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Mishima

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Scientific Reports|August 8, 2018
Chitin promotes antigen-specific Th2 cell-mediated murine asthma through induction of IL-33-mediated IL-1β production by DCsKen Arae, Hideaki Morita, Hirotoshi Unno, et al.
British Journal of Haematology|January 8, 2025
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 studyWataru Munakata, Takahiro Kumode, Hideki Goto, et al.
Acta Medica Okayama|October 27, 2010
Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in JapanHisakazu Nishimori, Shunji Takahashi, Katsuyuki Kiura, et al.
Cancer Science|November 3, 2023
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphomaKoji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
International Journal of Clinical Oncology|May 28, 2025
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trialKoji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
Transfusion|October 24, 2013
The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patientsMika Matsuhashi, Nelson H Tsuno, Shinji Sone, et al.
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Scientific Reports|August 8, 2018
Chitin promotes antigen-specific Th2 cell-mediated murine asthma through induction of IL-33-mediated IL-1β production by DCsKen Arae, Hideaki Morita, Hirotoshi Unno, et al.
British Journal of Haematology|January 8, 2025
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 studyWataru Munakata, Takahiro Kumode, Hideki Goto, et al.
Acta Medica Okayama|October 27, 2010
Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in JapanHisakazu Nishimori, Shunji Takahashi, Katsuyuki Kiura, et al.
Cancer Science|November 3, 2023
Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphomaKoji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
International Journal of Clinical Oncology|May 28, 2025
Efficacy and safety of epcoritamab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma: 3-year follow-up from the EPCORE NHL-3 trialKoji Izutsu, Takahiro Kumode, Junichiro Yuda, et al.
Transfusion|October 24, 2013
The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patientsMika Matsuhashi, Nelson H Tsuno, Shinji Sone, et al.
The New England Journal of Medicine|June 3, 2022
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell LymphomaMichael L Wang, Wojciech Jurczak, Mats Jerkeman, et al.
Pageof 11